You are here

  • Home
  • Archive
  • Volume 71, Issue Suppl 3
  • AB0461 Long-term use of adalimumab as monotherapy following attainment of low-disease activity: Subanalysis of the open-label extension of premier

Alerts

Article menu
Download PDFPDF
Scientific Abstracts
Abstracts accepted for publication
Rheumatoid arthritis – anti-TNF therapy
AB0461 Long-term use of adalimumab as monotherapy following attainment of low-disease activity: Subanalysis of the open-label extension of premier
You need to be signed in to access email alerts. If you have an account log in with your user name and password. If you don't have an account you can just enter your email address in the email box below.
Sign In to Email Alerts with your Email Address